应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02137 腾盛博药-B
未开盘 04-09 16:08:11
1.430
-0.020
-1.38%
最高
1.450
最低
1.420
成交量
85.10万
今开
1.440
昨收
1.450
日振幅
2.07%
总市值
10.32亿
流通市值
10.32亿
总股本
7.22亿
成交额
122.19万
换手率
0.12%
流通股本
7.22亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
腾盛博药-B公布3月股份变动月报表,已发行股份增加218,796股
公告速递 · 04-08 16:36
腾盛博药-B公布3月股份变动月报表,已发行股份增加218,796股
猪价探底背后:行业全链有望重塑
中国经营网 · 04-04
猪价探底背后:行业全链有望重塑
异动解读 | 业绩亏损收窄但收入低迷,腾盛博药-B盘中大跌5.48%
异动解读 · 03-20
异动解读 | 业绩亏损收窄但收入低迷,腾盛博药-B盘中大跌5.48%
腾盛博药-B (02137)2025年度业绩:实现0.018605亿元收入,亏损显著收窄
公告速递 · 03-19
腾盛博药-B (02137)2025年度业绩:实现0.018605亿元收入,亏损显著收窄
腾盛博药-B(02137)发布年度业绩,股东应占亏损2.23亿元 同比收窄56.19%
智通财经 · 03-19
腾盛博药-B(02137)发布年度业绩,股东应占亏损2.23亿元 同比收窄56.19%
腾盛博药-B盘中异动 早盘股价大跌5.16%
市场透视 · 03-11
腾盛博药-B盘中异动 早盘股价大跌5.16%
每周股票复盘:清溢光电(688138)核心技术人员洪志华离职
证券之星 · 03-08
每周股票复盘:清溢光电(688138)核心技术人员洪志华离职
腾盛博药-B(02137)2026年2月股份变动月报表:股本小幅增长7,750股
公告速递 · 03-04
腾盛博药-B(02137)2026年2月股份变动月报表:股本小幅增长7,750股
腾盛博药-B盘中异动 临近午盘快速下跌5.52%
市场透视 · 03-04
腾盛博药-B盘中异动 临近午盘快速下跌5.52%
腾盛博药-B盘中异动 早盘股价大跌5.77%报1.470港元
市场透视 · 03-02
腾盛博药-B盘中异动 早盘股价大跌5.77%报1.470港元
腾盛博药-B02月26日主力净流出83.3万元 散户资金买入
市场透视 · 02-26
腾盛博药-B02月26日主力净流出83.3万元 散户资金买入
腾盛博药-B盘中异动 急速上涨5.37%
市场透视 · 02-13
腾盛博药-B盘中异动 急速上涨5.37%
腾盛博药-B02月10日主力净流入177.7万元 散户资金抛售
市场透视 · 02-10
腾盛博药-B02月10日主力净流入177.7万元 散户资金抛售
腾盛博药(2137)更新1月股份变动月报表 股本小幅增至约7.215亿股
公告速递 · 02-04
腾盛博药(2137)更新1月股份变动月报表 股本小幅增至约7.215亿股
腾盛博药-B盘中异动 早盘股价大跌5.30%报1.430港元
市场透视 · 02-02
腾盛博药-B盘中异动 早盘股价大跌5.30%报1.430港元
腾盛博药-B01月30日遭主力抛售46.1万元
市场透视 · 01-30
腾盛博药-B01月30日遭主力抛售46.1万元
腾盛博药-B01月28日主力净流入35.1万元 散户资金抛售
市场透视 · 01-28
腾盛博药-B01月28日主力净流入35.1万元 散户资金抛售
腾盛博药-B01月13日主力净流入11.8万元 散户资金抛售
市场透视 · 01-13
腾盛博药-B01月13日主力净流入11.8万元 散户资金抛售
腾盛博药-B盘中异动 临近午盘快速上涨5.26%报1.600港元
市场透视 · 01-12
腾盛博药-B盘中异动 临近午盘快速上涨5.26%报1.600港元
腾盛博药-B01月07日主力净流入16.6万元 散户资金抛售
市场透视 · 01-07
腾盛博药-B01月07日主力净流入16.6万元 散户资金抛售
加载更多
公司概况
公司名称:
腾盛博药-B
所属市场:
SEHK
上市日期:
--
主营业务:
腾盛博药生物科技有限公司是一家主要从事感染性疾病以及中枢神经系统疾病治疗方法开发的生物科技公司。该公司研发的产品主要包括乙型肝炎病(HBV)免疫治疗候选药物BRII-179、靶向乙型肝炎表面抗原(HBsAg)的研究性HBV中和单克隆抗体Tobevibart、以及用于治疗多重耐药性(MDR)和广泛耐药性(XDR)的革兰氏阴性菌感染的合成脂肽soralimixin(BRII-693)等。该公司主要在中国国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02137","market":"HK","secType":"STK","nameCN":"腾盛博药-B","latestPrice":1.43,"timestamp":1775722091587,"preClose":1.45,"halted":0,"volume":851000,"delay":0,"changeRate":-0.013793103448275874,"floatShares":722000000,"shares":722000000,"eps":-0.35385878826930306,"marketStatus":"未开盘","change":-0.02,"latestTime":"04-09 16:08:11","open":1.44,"high":1.45,"low":1.42,"amount":1221905,"amplitude":0.02069,"askPrice":1.44,"askSize":29000,"bidPrice":1.43,"bidSize":56000,"shortable":0,"etf":0,"ttmEps":-0.35385878826930306,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775784600000},"marketStatusCode":0,"adr":0,"listingDate":1626105600000,"exchange":"SEHK","adjPreClose":1.45,"openAndCloseTimeList":[[1775698200000,1775707200000],[1775710800000,1775721600000]],"volumeRatio":1.1146037981221317,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02137","defaultTab":"news","newsList":[{"id":"1195379830","title":"腾盛博药-B公布3月股份变动月报表,已发行股份增加218,796股","url":"https://stock-news.laohu8.com/highlight/detail?id=1195379830","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195379830?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:36","pubTimestamp":1775637402,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年4月8日公告了截至2026年3月31日的股份变动月报表。根据报告期内信息,公司法定股本维持1,200,000,000股不变,每股面值为USD 0.000005,注册股本对应USD 6,000。报告期内,普通股已发行股份由上月底的721,540,793股增至721,759,589股,较此前增加218,796股;库存股份数目维持在12,723,500股不变。截至3月末,公司已发行股份总数为734,483,089股。根据期权及其他激励计划数据,本月合计行使股份期权增发178,000股,并通过奖励计划增发40,796股,合计新增218,796股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624662148","title":"猪价探底背后:行业全链有望重塑","url":"https://stock-news.laohu8.com/highlight/detail?id=2624662148","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624662148?lang=zh_cn&edition=full","pubTime":"2026-04-04 03:58","pubTimestamp":1775246320,"startTime":"0","endTime":"0","summary":"供需波动导致我国生猪价格持续下探,进而引发行业内外的广泛讨论。数据显示,截至3月底,全国外三元生猪均价在9.4元/公斤左右,同比降幅30%,比年初水平下降20%。多位行业人士告诉《中国经营报》记者,按全国平均水平,当前生猪养殖完全成本仍在13元/公斤左右,按出栏体重125公斤推算,意味着头均亏损450元左右。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604043695328679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002124","002567","BK0188","BK0197","02714","BK0194","02137","BK0039","002458","BK0070","300498","BK0183","BK0201","BK0240","BK0238","BK0196","BK1161","000876","BK1574","BK1237","BK0056","002714","BK0195","BK0187","LU1655091616.SGD","BK0012","BK1587","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101608081","title":"异动解读 | 业绩亏损收窄但收入低迷,腾盛博药-B盘中大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=1101608081","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101608081?lang=zh_cn&edition=full","pubTime":"2026-03-20 09:36","pubTimestamp":1773970597,"startTime":"0","endTime":"0","summary":"腾盛博药-B(02137.HK)今日盘中股价大跌5.48%,引起了市场的广泛关注。消息面上,公司于前一交易日盘后公布了2025年度业绩。数据显示,公司全年收入仅为1,861万元人民币,虽然亏损较上年同期的5.08亿元收窄至2.23亿元,每股亏损31分,且不派息,但整体业绩表现仍显疲弱。分析人士认为,尽管亏损有所收窄,但公司收入规模过小且持续处于亏损状态,可能未能达到市场预期,从而引发了投资者的担忧和抛售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173598131","title":"腾盛博药-B (02137)2025年度业绩:实现0.018605亿元收入,亏损显著收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1173598131","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173598131?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:09","pubTimestamp":1773918580,"startTime":"0","endTime":"0","summary":"腾盛博药-B 截至2025年12月31日止年度首次录得收入人民币0.018605亿元,主要来自许可费收入及技术转移协议信用取得的款项。同期年内亏损为人民币0.224067亿元,较上一年度的人民币0.512381亿元减少人民币0.288314亿元。报告期内,研究开支由上一年度的人民币0.249847亿元降至人民币0.212899亿元,主要源于第三方合约成本及雇员成本降低。行政开支则由人民币0.153155亿元降至人民币0.10945亿元,主要与员工成本及专业费用减少有关。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620024498","title":"腾盛博药-B(02137)发布年度业绩,股东应占亏损2.23亿元 同比收窄56.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620024498","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620024498?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:04","pubTimestamp":1773918289,"startTime":"0","endTime":"0","summary":"智通财经APP讯,腾盛博药-B(02137)发布截至2025年12月31日止年度业绩,该公司取得收益人民币1860.5万元(单位下同),去年同期收益为0元;公司拥有人应占年内亏损2.23亿元,同比收窄56.19%;每股亏损0.31元。公告称,收益增加主要归因于根据与健康元集团订立的知识产权许可及技术转让协议所收取的款项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1587","BK1161","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618976539","title":"腾盛博药-B盘中异动 早盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618976539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618976539?lang=zh_cn&edition=full","pubTime":"2026-03-11 09:33","pubTimestamp":1773192826,"startTime":"0","endTime":"0","summary":"2026年03月11日早盘09时33分,腾盛博药-B股票出现异动,股价快速下挫5.16%。截至发稿,该股报1.470港元/股,成交量15.7万股,换手率0.02%,振幅3.87%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。腾盛博药-B股票所在的生物技术行业中,整体跌幅为0.27%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家主要从事感染性疾病以及中枢神经系统疾病治疗方法开发的生物科技公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311093346a6b6a031&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311093346a6b6a031&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1587","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617682756","title":"每周股票复盘:清溢光电(688138)核心技术人员洪志华离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2617682756","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617682756?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:22","pubTimestamp":1772907732,"startTime":"0","endTime":"0","summary":"中信证券股份有限公司关于深圳清溢光电股份有限公司核心技术人员离职的核查意见深圳清溢光电股份有限公司核心技术人员洪志华先生因个人原因离职,已办理工作交接,不再担任公司任何职务。洪志华持有公司股票130,000股,任职期间参与的知识产权归属公司,无纠纷。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1587","BK1574","688138","02137","BK1161","BK0214"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195745780","title":"腾盛博药-B(02137)2026年2月股份变动月报表:股本小幅增长7,750股","url":"https://stock-news.laohu8.com/highlight/detail?id=1195745780","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195745780?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:53","pubTimestamp":1772614382,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年3月4日发布了2026年2月股份变动月报表,披露报告期内公司股本结构及股份变动情况。报告期内,公司法定/注册股本未发生变化,维持在1,200,000,000股,面值为每股USD 0.000005,总额为USD 6,000。期权与激励计划方面,首次公开发售股份激励计划、首次公开发售后购股权计划及2023年购股权计划在报告期内均有部分期权失效,但未有期权行使导致新股发行。截至2026年2月末,公司股本总数较上月末略有增加,整体维持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616275559","title":"腾盛博药-B盘中异动 临近午盘快速下跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616275559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616275559?lang=zh_cn&edition=full","pubTime":"2026-03-04 11:35","pubTimestamp":1772595313,"startTime":"0","endTime":"0","summary":"2026年03月04日临近午盘11时35分,腾盛博药-B股票出现异动,股价快速下跌5.52%。截至发稿,该股报1.370港元/股,成交量77.1万股,换手率0.11%,振幅4.83%。腾盛博药-B股票所在的生物技术行业中,整体跌幅为3.37%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家主要从事感染性疾病以及中枢神经系统疾病治疗方法开发的生物科技公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304113514a449592c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304113514a449592c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02137","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616035180","title":"腾盛博药-B盘中异动 早盘股价大跌5.77%报1.470港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616035180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616035180?lang=zh_cn&edition=full","pubTime":"2026-03-02 09:56","pubTimestamp":1772416561,"startTime":"0","endTime":"0","summary":"2026年03月02日早盘09时56分,腾盛博药-B股票出现异动,股价快速下挫5.77%。截至发稿,该股报1.470港元/股,成交量86.4万股,换手率0.12%,振幅5.13%。资金方面,该股资金流入3.304万港元,流出125.695万港元。腾盛博药-B股票所在的生物技术行业中,整体跌幅为1.63%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家主要从事感染性疾病以及中枢神经系统疾病治疗方法开发的生物科技公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302095601a43fdd71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302095601a43fdd71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1587","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614008079","title":"腾盛博药-B02月26日主力净流出83.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614008079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614008079?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:15","pubTimestamp":1772093754,"startTime":"0","endTime":"0","summary":"02月26日, 腾盛博药-B股价跌3.77%,报收1.53元,成交金额316.3万元,换手率0.28%,振幅4.40%,量比2.78。腾盛博药-B今日主力资金净流出83.3万元,上一交易日主力净流出0万元。该股主力净额占比0.07%,港股市场排名2615/2718。|02月26日主力加仓幅度排名||#|股票简称|主力净额占比|#|鸿盛昌资源|22.52%|#|美高域|2.21%|#|立高控股|1.78%|#|...|...|#2616|腾盛博药-B|-0.08%|(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162018a4caa4b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162018a4caa4b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02137","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611152962","title":"腾盛博药-B盘中异动 急速上涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611152962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611152962?lang=zh_cn&edition=full","pubTime":"2026-02-13 14:36","pubTimestamp":1770964579,"startTime":"0","endTime":"0","summary":"2026年02月13日下午盘14时36分,腾盛博药-B股票出现波动,股价快速上涨5.37%。截至发稿,该股报1.570港元/股,成交量145.35万股,换手率0.20%,振幅7.38%。腾盛博药-B股票所在的生物技术行业中,整体跌幅为1.71%。其相关个股中,再鼎医药、腾盛博药-B、基石药业-B涨幅较大,振幅较大的相关个股有北海康成-B、荃信生物-B、华昊中天医药-B,振幅分别为10.45%、8.48%、8.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021314362097a60de0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021314362097a60de0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","02137","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610831699","title":"腾盛博药-B02月10日主力净流入177.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610831699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610831699?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:15","pubTimestamp":1770711348,"startTime":"0","endTime":"0","summary":"02月10日, 腾盛博药-B股价涨5.41%,报收1.56元,成交金额396.7万元,换手率0.35%,振幅7.43%,量比2.19。腾盛博药-B今日主力资金净流入177.7万元,上一交易日主力净流出118.6万元。该股近5个交易日上涨4.70%,主力资金累计净流入59.1万元;近20日主力资金累计净流出235.1万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162006a492a80f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162006a492a80f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1161","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195724843","title":"腾盛博药(2137)更新1月股份变动月报表 股本小幅增至约7.215亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1195724843","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195724843?lang=zh_cn&edition=full","pubTime":"2026-02-04 17:15","pubTimestamp":1770196544,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年2月4日公布截至2026年1月31日的月度股份变动情况。报告显示,公司注册股本本月维持1,200,000,000股,面值0.000005美元,总额6,000美元。期末已发行普通股数量约为721,533,043股,较上月增加355,981股,库存股数则保持不变,为12,723,500股。公司当月主要通过股份期权及其他股权激励计划增发股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608686548","title":"腾盛博药-B盘中异动 早盘股价大跌5.30%报1.430港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608686548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608686548?lang=zh_cn&edition=full","pubTime":"2026-02-02 11:29","pubTimestamp":1770002958,"startTime":"0","endTime":"0","summary":"2026年02月02日早盘11时29分,腾盛博药-B股票出现波动,股价大幅下跌5.30%。截至发稿,该股报1.430港元/股,成交量85.6万股,换手率0.12%,振幅5.30%。资金方面,该股资金流入35.368万港元,流出91.7205万港元。腾盛博药-B股票所在的生物技术行业中,整体跌幅为3.51%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家主要从事感染性疾病以及中枢神经系统疾病治疗方法开发的生物科技公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202112919953f5bf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202112919953f5bf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","BK1574","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607014463","title":"腾盛博药-B01月30日遭主力抛售46.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607014463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607014463?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:16","pubTimestamp":1769760966,"startTime":"0","endTime":"0","summary":"01月30日, 腾盛博药-B股价跌4.43%,报收1.51元,成交金额240.0万元,换手率0.22%,振幅3.16%,量比1.09。腾盛博药-B今日主力资金净流出46.1万元,上一交易日主力净流出23.0万元。该股近5个交易日上涨2.61%,主力资金累计净流出99.2万元;近20日主力资金累计净流出213.7万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162804a6bf3ef3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162804a6bf3ef3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1587","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607905723","title":"腾盛博药-B01月28日主力净流入35.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2607905723","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607905723?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:15","pubTimestamp":1769588140,"startTime":"0","endTime":"0","summary":"01月28日, 腾盛博药-B股价涨4.61%,报收1.59元,成交金额387.7万元,换手率0.34%,振幅9.87%,量比2.74。腾盛博药-B今日主力资金净流入35.1万元,上一交易日主力净流出18.8万元。该股近5个交易日上涨4.61%,主力资金累计净流出14.7万元;近20日主力资金累计净流出171.8万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162040a6b66bbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162040a6b66bbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02137","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603682461","title":"腾盛博药-B01月13日主力净流入11.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603682461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603682461?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:15","pubTimestamp":1768292114,"startTime":"0","endTime":"0","summary":"01月13日, 腾盛博药-B股价涨2.48%,报收1.65元,成交金额267.2万元,换手率0.22%,振幅5.59%,量比1.43。腾盛博药-B今日主力资金净流入11.8万元,上一交易日主力净流出13.9万元。该股近5个交易日上涨10.74%,主力资金累计净流入67.5万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出451.0万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113161609a714dff4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113161609a714dff4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02137","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602602855","title":"腾盛博药-B盘中异动 临近午盘快速上涨5.26%报1.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602602855","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602602855?lang=zh_cn&edition=full","pubTime":"2026-01-12 11:44","pubTimestamp":1768189494,"startTime":"0","endTime":"0","summary":"2026年01月12日临近午盘11时44分,腾盛博药-B股票出现波动,股价大幅上涨5.26%。截至发稿,该股报1.600港元/股,成交量66.8万股,换手率0.09%,振幅4.61%。资金方面,该股资金流入63.818万港元,流出37.278万港元。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。腾盛博药-B股票所在的生物技术行业中,整体涨幅为0.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011211445497a1662c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011211445497a1662c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02137","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601384708","title":"腾盛博药-B01月07日主力净流入16.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601384708","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601384708?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:15","pubTimestamp":1767773727,"startTime":"0","endTime":"0","summary":"01月07日, 腾盛博药-B股价涨4.70%,报收1.56元,成交金额127.7万元,换手率0.12%,振幅4.70%,量比0.63。腾盛博药-B今日主力资金净流入16.6万元,上一交易日主力净流出0万元。该股近5个交易日上涨9.15%,主力资金累计净流出25.3万元;近20日主力资金累计净流出723.2万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107161718a4a6d078&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107161718a4a6d078&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02137","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.briibio.com","stockEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":-0.0774},{"period":"3month","weight":-0.0592},{"period":"6month","weight":-0.2921},{"period":"1year","weight":-0.128},{"period":"ytd","weight":0.0142}],"compareEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":-0.008},{"period":"3month","weight":-0.0183},{"period":"6month","weight":-0.0205},{"period":"1year","weight":0.2708},{"period":"ytd","weight":0.0048}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"腾盛博药生物科技有限公司是一家主要从事感染性疾病以及中枢神经系统疾病治疗方法开发的生物科技公司。该公司研发的产品主要包括乙型肝炎病(HBV)免疫治疗候选药物BRII-179、靶向乙型肝炎表面抗原(HBsAg)的研究性HBV中和单克隆抗体Tobevibart、以及用于治疗多重耐药性(MDR)和广泛耐药性(XDR)的革兰氏阴性菌感染的合成脂肽soralimixin(BRII-693)等。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.040695},{"month":2,"riseRate":0.6,"avgChangeRate":0.049398},{"month":3,"riseRate":0.2,"avgChangeRate":-0.163076},{"month":4,"riseRate":0.4,"avgChangeRate":-0.004033},{"month":5,"riseRate":0,"avgChangeRate":-0.064507},{"month":6,"riseRate":0.25,"avgChangeRate":-0.093488},{"month":7,"riseRate":1,"avgChangeRate":0.097158},{"month":8,"riseRate":0.2,"avgChangeRate":0.004254},{"month":9,"riseRate":0.6,"avgChangeRate":-0.00155},{"month":10,"riseRate":0.2,"avgChangeRate":-0.127852},{"month":11,"riseRate":0.6,"avgChangeRate":0.286305},{"month":12,"riseRate":0.2,"avgChangeRate":-0.154392}],"exchange":"SEHK","name":"腾盛博药-B","nameEN":"BRII-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"腾盛博药-B,02137,腾盛博药-B股票,腾盛博药-B股票老虎,腾盛博药-B股票老虎国际,腾盛博药-B行情,腾盛博药-B股票行情,腾盛博药-B股价,腾盛博药-B股市,腾盛博药-B股票价格,腾盛博药-B股票交易,腾盛博药-B股票购买,腾盛博药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}